<DOC>
	<DOC>NCT01016145</DOC>
	<brief_summary>The objective of this study is to evaluate predictors of response to antipsychotic medication in subjects with schizophrenia. The investigators will evaluate psychopathology,brain MRI, genetics and neuropsychological profile. Two groups of treatment will be compared: first generation antipsychotics vs. second generation antipsychotics. Participants will be randomized to one of the groups. Trial duration: 12 weeks.</brief_summary>
	<brief_title>Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Chlorpromazine</mesh_term>
	<criteria>Schizophrenia or schizoaffective disorder Age: 1845 years olde Less than 10 years of diagnosis Acute exacerbation of psychotic symptoms Use of clozapine Clinical unstable disease Delirium and cognitive disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>predictors of response</keyword>
	<keyword>antipsychotics</keyword>
	<keyword>18-45 years old</keyword>
	<keyword>non-refractory</keyword>
</DOC>